CRISPR Therapeutics (CRSP) Stock Highlights

40.72 | +0.84%

2024-12-21 02:26:13

CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPRs most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.

Statistics

Range Today

39.41 41.01

Volume Today 3.13M

Range 1 Year

39.8 91.1

Volume 1 Year 387.39M

Range 3 Year

37.55 91.1

Volume 3 Year 1.14B

Range 10 Year

11.63 220.2

Volume 10 Year 2.33B

Highlights

Market Capitalization 4.41B (mid)

Floating Shares 83.77M

Current Price 40.72

Price To Earnings -18.42

Price To Revenue 13.06

Price To Book 2.22

Earnings Per Share -2.78

Payout Ratio 0%

Performance

Latest +0.84%

1 Month -13.62%

3 Months -17.57%

6 Months -32.19%

1 Year -38.7%

3 Years -48.85%

5 Years -37.51%

10 Years +171.47%

Benchmarks

Market Capitalization

26 / 368

Gross Profits

278 / 278

Total Revenue

66 / 300

Total Rank

306 / 368

Free Cashflow

329 / 352

Performance 5 years

155 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.